Denosumab

This Shared Care Guideline is available on the SY IMOC website under 'South Yorkshire IMOC Shared Care Protocols'.

SY Denosumab (Prolia®) Shared Care Guideline

In November 2022 guidance was developed on Denosumab (Prolia®) for Primary Care Clinicians; where patients have been previously initiated on Denosumab (Prolia®) as Shared Care by Barnsley Osteoporosis Service  (patients are no longer under hospital supervision). 

Denosumab guidelines for primary care clinicians.pdf

Date: 31 August 2022 to 01 January 2099

  • Due for review
    31 August 2027
  • Type
    Shared Care Guidelines
  • Clinical support group
    • Cancer, Palliative Care, Pain and Older People
    • Dermatology, MSK and Rheumatology
  • Traffic Light
    Amber (SCG)
  • Conditions and indicators
    Osteoporosis

Do you want to add this to your CPD record?

Did you find this page helpful?